To determine whether p53 contributes directly to these universal and outcome-specific transcriptional responses, we mapped p53 binding sites by chromatin-immunoprecipitation and sequencing (ChIP-seq) in the tumor cell lines at 24 h following mock treatment or Tam-mediated p53 restoration (Dataset S3). Here, TP53 is linked to neoplasm.